Detection of lung and chest tumours using99tcm-tetrofosmin comparison with 201t1

Nuclear Medicine Communications

Volumn 19, Issue 7, 1998, Pages 657-

  Arbab, A S ^a   Toyama, K ^a   Arak, T ^a   Araki, T ^a   Koizumi, K ^b  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b TOKYO MEDICAL UNIVERSITY HACHIOJI MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TETROFOSMIN TC 99M; THALLIUM 201;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCINTISCANNING; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; LUNG CANCER; LYMPH NODE METASTASIS; MALE; THORAX TUMOR;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; THALLIUM RADIOISOTOPES; THORACIC NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031849679     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199807000-00007     Document Type: Article

References (19)

1. Kelly JD, Forster AM, HigleyTechnetium-99m-tetro-fosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993; 34: 222-227.
2. Jain D, Wackers FJT, Mattera J, McMahon M, Sinusus AJ, Zaret BL. Biokinetics of technetium-99m-tetrofosmin: Myocardial perfusion agent. Implication for one-day protocol. J Nucl Med 1993; 34: 1254-1259.
3. Rigo P, Leclercq B, Itti R, Lahiri A, Braat S. Technetium-99m-tetrofosmin myocardial imaging: A comparison with thallium-201 and angiography. J Nucl Med 1994; 35: 587-593.
4. Aktolun C, Bayhan H, Kir M. Clinical experience with 99Tcm MIBI imaging in patients with malignant tumors: Preliminary results and comparison with 201T1. Clin Nucl Med 1992; 17: 171-176.
5. Waxman AD, Ramanna L, Memsic LD et al. Thallium scintigraphy in the evaluation of mass abnormality of the breast. J Nucl Med 1993; 34: 18-23.
6. O’Tauma LA, Treves ST, Larar JN et al. Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: A within-subject comparison. J Nucl Med 1993; 34: 1045-1051.
7. Arbab AS, Koizumi K, Arai T, Toyama K, Araki T. Application of 99Tcm-tetrofosmin as a tumor imaging agent: Comparison with 201T1. Ann Nucl Med 1996; 10: 271-274.
8. Tonami N, Shuke N, Yokoyama K et al. Thallium-201 single photon emission computed tomography in the evaluation of suspected lung cancer. J Nucl Med 1989; 30: 997-1004.
9. Ichihara T, Ogawa K, Motomura N, Kubo A, Hishimoto S. Compton scatter compensation using the triple-energy window method: Single-and dual-isotope SPECT. J Nucl Med 1993; 34: 2216-2221.
10. Maublant J, Veyre A, Platts EA, Pickett RD. Uptake of 99Tcm-tetrofosmin in isolated mitochondria: Evidence for an active mechanism (abstract). J Nucl Med 1994; 35: 46p-47p.
11. Arbab AS, Koizumi K, Toyama K, Araki T. Uptake of 99Tcm-tetrofosmin, 99Tcm-MIBI and 201T1 in tumor cell lines. J Nucl Med 1996; 37: 1551-1556.
12. Arbab AS, Koizumi K, Toyama K, Arai T, Araki T. Ion transport systems in the uptake of –Tcm-tetrofosmin, —Tcm-MIBI and 201T1 in a tumor cell line. Nucl Med Com-mun 1997; 18: 235-240.
13. Basoglu T, Sahin M, Coskun C, Koparan A, Bernay I, Erkan L. Technetium-99m-tetrofosmin uptake in malignant lung tumors. Eur J Nucl Med 1995; 22: 687-689.
14. Atasever T, Gokcora N, Vural G, Cetin N, Ozturk C, Unlu M. Evaluation of malignant and benign lung lesions with 99Tcm-tetrofosmin. Nucl Med Commun 1996; 17: 577-582.
15. Ballinger JR, Bannerman J, Boxen I, Firby P, Hartman NG, Moore MJ. Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: In vitro studies in multi-drug resistant breast tumor cells. J Nucl Med 1996; 37: 1578-1582.
16. Kostakoglu L, Elahi N, Kiratli P et al. Clinical validation of the influence of P-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors. J Nucl Med 1997; 38: 1003-1008.
17. Luker GD, Fracasso PM, Dobkin J, Piwnica-Worms D. Modulation of the multidrug resistance P-glycoprotein: Detection with technetium-99m-sestamibi in vivo. J Nucl Med 1997; 38: 369-372.
18. Namba R, Narabayashi I, Matsui R et al. Evaluation of 201T1 SPECT for monitoring the treatment of pulmonary and mediastinal tumors. Ann Nucl Med 1995; 9: 65-74.
19. Arbab AS, Koizumi K, Toyama K, Arai T, Yoshitomi T, Araki T. Detection of lung lesions and lymph nodes with 201T1 SPET. Nucl Med Commun 1998; 19: 411-416.